Warning Letter — International Medication Systems Limited
The FDA issued a Warning Letter to International Medication Systems Limited on July 2, 2026, following an evaluation by the Center for Drug Evaluation and Research (CDER).
This affects International Medication Systems Limited, as well as their personnel involved in drug manufacturing, quality control, and regulatory compliance.
A Warning Letter from CDER indicates that the firm's responses to previous inspectional observations were likely insufficient to address regulatory concerns. This development suggests a formal escalation of enforcement that could lead to broader regulatory sanctions if the underlying compliance issues are not resolved.
Regulatory and Quality teams should review recent inspection observations for outstanding deficiencies. Facilities should prioritize the remediation of issues cited by CDER to prevent further enforcement actions such as import alerts or seizure.
FDA Warning Letter issued to: International Medication Systems Limited. 07/02/2026 — Center for Drug Evaluation and Research (CDER). Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/international-medication-systems-limited-727560-07022026
Open in openFDA / FDA.gov